DE3567471D1 - Method for producing a polymer or copolymer of lactic acid and/or glycolic acid - Google Patents

Method for producing a polymer or copolymer of lactic acid and/or glycolic acid

Info

Publication number
DE3567471D1
DE3567471D1 DE8585304734T DE3567471T DE3567471D1 DE 3567471 D1 DE3567471 D1 DE 3567471D1 DE 8585304734 T DE8585304734 T DE 8585304734T DE 3567471 T DE3567471 T DE 3567471T DE 3567471 D1 DE3567471 D1 DE 3567471D1
Authority
DE
Germany
Prior art keywords
copolymer
polymer
producing
acid
lactic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585304734T
Other languages
English (en)
Inventor
Motoaki Tanaka
Yasuaki Ogawa
Tsutomu Miyagawa
Toshio Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15266918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3567471(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP59140356A external-priority patent/JPH0678425B2/ja
Application filed by Wako Pure Chemical Industries Ltd, Takeda Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Application granted granted Critical
Publication of DE3567471D1 publication Critical patent/DE3567471D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
DE8585304734T 1984-07-06 1985-07-03 Method for producing a polymer or copolymer of lactic acid and/or glycolic acid Expired DE3567471D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59140356A JPH0678425B2 (ja) 1984-07-06 1984-07-06 重合体の新規製造法

Publications (1)

Publication Number Publication Date
DE3567471D1 true DE3567471D1 (en) 1989-02-16

Family

ID=15266918

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8585304734T Expired DE3567471D1 (en) 1984-07-06 1985-07-03 Method for producing a polymer or copolymer of lactic acid and/or glycolic acid
DE8585304733T Expired DE3567470D1 (en) 1984-07-06 1985-07-03 Copolymer and method for producing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8585304733T Expired DE3567470D1 (en) 1984-07-06 1985-07-03 Copolymer and method for producing the same

Country Status (8)

Country Link
US (2) US4677191A (de)
EP (2) EP0172636B2 (de)
AT (2) ATE39935T1 (de)
BG (1) BG61520B2 (de)
CA (2) CA1256638A (de)
DE (2) DE3567471D1 (de)
HK (1) HK19592A (de)
SG (1) SG108191G (de)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
GB8609537D0 (en) * 1986-04-18 1986-05-21 Ici Plc Polyesters
DE3720806C2 (de) * 1986-07-03 1997-08-21 Clariant Finance Bvi Ltd Verwendung eines Stabilisators in Peroxydbleichverfahren
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3641692A1 (de) * 1986-12-06 1988-06-09 Boehringer Ingelheim Kg Katalysatorfreie resorbierbare homopolymere und copolymere
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
EP0428620B1 (de) * 1988-08-08 1999-03-03 Biopak Technology, Ltd. Verfahren zur Weichmachung von Lactidpolymerisaten
AU634723B2 (en) * 1988-08-08 1993-03-04 Biopak Technology, Ltd. Degradable thermoplastic from lactides
US5250584A (en) * 1988-08-31 1993-10-05 G-C Dental Industrial Corp. Periodontium-regenerative materials
JP2714454B2 (ja) * 1988-11-07 1998-02-16 三井東圧化学株式会社 生体吸収性ポリエステルの製造方法
US4990336A (en) * 1989-02-08 1991-02-05 Biosearch, Inc. Sustained release dosage form
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
DE4005415C2 (de) * 1990-02-21 1996-04-11 Boehringer Ingelheim Kg Verfahren zum Herstellen von Polyestern auf der Basis von Hydroxycarbonsäuren
US5288496A (en) * 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
MY108621A (en) * 1990-08-01 1996-10-31 Novartis Ag Polylactide preparation and purification
US6353030B1 (en) * 1990-08-01 2002-03-05 Novartis Ag Relating to organic compounds
NO302481B1 (no) 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
IT1249045B (it) * 1991-02-21 1995-02-11 Himont Inc Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi ottenuti
US6005067A (en) * 1992-01-24 1999-12-21 Cargill Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US6326458B1 (en) 1992-01-24 2001-12-04 Cargill, Inc. Continuous process for the manufacture of lactide and lactide polymers
US5247058A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5142023A (en) * 1992-01-24 1992-08-25 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5258488A (en) * 1992-01-24 1993-11-02 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5247059A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for the manufacture of a purified lactide from esters of lactic acid
US5294469A (en) * 1992-06-17 1994-03-15 Mitsui Toatsu Chemicals, Incorporated Industrial woven fabric and composite sheet comprising same
US5758053A (en) * 1992-07-22 1998-05-26 Hitachi, Ltd. Fault handling and recovery for system having plural processors
DK0615555T3 (da) * 1992-10-02 2001-07-09 Cargill Inc Tekstilmateriale af smeltestabil lactidpolymer og fremgangsmåde til fremstilling deraf
ES2123668T3 (es) * 1992-10-02 1999-01-16 Cargill Inc Papel que tiene un recubrimiento de polimero de lactida estable en estado fundido y procedimiento para su fabricacion.
US6005068A (en) * 1992-10-02 1999-12-21 Cargill Incorporated Melt-stable amorphous lactide polymer film and process for manufacture thereof
US5338822A (en) * 1992-10-02 1994-08-16 Cargill, Incorporated Melt-stable lactide polymer composition and process for manufacture thereof
US5643595A (en) * 1992-11-24 1997-07-01 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
NZ276088A (en) 1993-11-19 1999-07-29 Janssen Pharmaceutica Nv [(1,2-benzisoxazol-3-yl)-1-piperidinyl-alkyl-6,7,8,9-tetrahydro-4h- pyrido[1,2-a]-pyrimidin-4-one derivatives (ie risperidone)
WO1997008220A1 (fr) * 1995-08-29 1997-03-06 Kyowa Hakko Kogyo Co., Ltd. Processus de production d'acide polyhydroxy carboxylique
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
EP0823448A4 (de) * 1996-02-23 1998-08-12 Kyowa Hakko Kogyo Kk Verfahren zur herstellung von polyhydroxycarbonsäure
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6663899B2 (en) 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6733767B2 (en) * 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US6217844B1 (en) * 1998-04-27 2001-04-17 Praecis Pharmaceuticals, Inc. Methods for detecting lesions in dense breast tissue using LHRH antagonists
DE60019638T2 (de) 1999-12-10 2005-09-22 Equipolymers Gmbh Katalysatorsysteme für polykondensationsreaktionen
US6960626B2 (en) * 2000-01-21 2005-11-01 Cyclics Corporation Intimate physical mixtures containing macrocyclic polyester oligomer and filler
PT1310517E (pt) 2000-08-07 2006-05-31 Wako Pure Chem Ind Ltd Polimero de acido lactico e processo para a sua producao
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
CA2418347C (en) * 2000-08-16 2010-03-30 Tyco Healthcare Group Lp High consistency absorbable polymeric resin
US7767781B2 (en) 2000-09-01 2010-08-03 Cyclics Corporation Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
US7750109B2 (en) 2000-09-01 2010-07-06 Cyclics Corporation Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
EP1408876A4 (de) 2001-06-22 2004-09-22 Durect Corp Koaxiale implantate nullter ordnung mit verlängerter freisetzung
ATE305931T1 (de) 2001-06-27 2005-10-15 Cyclics Corp Isolierung, formulierung und informbringen von makrocyclischen oligoestern
TWI225416B (en) 2001-06-29 2004-12-21 Takeda Chemical Industries Ltd Sustained-release composition and process for producing the same
TW200526267A (en) 2001-06-29 2005-08-16 Takeda Chemical Industries Ltd Controlled release composition and method of producing the same
JP2003192773A (ja) * 2001-12-26 2003-07-09 Mitsui Chemicals Inc 生体吸収性ポリヒドロキシカルボン酸及びその製造法
US6849600B2 (en) * 2002-03-25 2005-02-01 The Regents Of The University Of California, Berkeley Corticotropin-releasing hormone analogs
KR100684682B1 (ko) * 2002-09-24 2007-02-22 아사히 가세이 케미칼즈 가부시키가이샤 글리콜산 공중합체 및 그의 제조 방법
EP1440992A1 (de) * 2003-01-21 2004-07-28 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Katalysatorzusammensetzung für die (Co)polymerisation von Lactid und Glycolid
US20050112087A1 (en) * 2003-04-29 2005-05-26 Musso Gary F. Pharmaceutical formulations for sustained drug delivery
US20060193825A1 (en) * 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
CA2915574C (en) 2003-07-18 2017-02-07 Oakwood Laboratories, L.L.C. Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
US20060074025A1 (en) * 2003-12-26 2006-04-06 Nastech Pharmaceutical Company Inc. Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
US20080318837A1 (en) * 2003-12-26 2008-12-25 Nastech Pharmaceutical Company Inc. Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
US20060210614A1 (en) * 2003-12-26 2006-09-21 Nastech Pharmaceutical Company Inc. Method of treatment of a metabolic disease using intranasal administration of exendin peptide
DE112005000965T5 (de) * 2004-04-28 2007-03-22 Keio University Depolymerisationsverfahren für Polymere mit Esterbindung in der Hauptkette und Verfahren zur Herstellung von Polymeren mit Esterbindung in der Hauptkette aus dem Depolymerisationsprodukt
ES2357243T3 (es) * 2004-05-21 2011-04-20 Micro Therapeutics, Inc. Espirales metálicas entrelazadas con polímeros o fibras biológicos o biodegradables o sintéticos para la embolización de una cavidad corporal.
US20070254314A1 (en) * 2004-09-16 2007-11-01 Geier Mark R Methods of treating autism and autism spectrum disorders
ATE448737T1 (de) 2004-09-22 2009-12-15 Dendron Gmbh Vorrichtung zur implantation von mikrowendeln
DE102005019782A1 (de) * 2005-04-28 2006-11-09 Dendron Gmbh Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel
EP1716847B1 (de) * 2005-04-28 2008-01-02 Nipro Corporation Bioabsorbierbare pharmazeutische Zusammensetzung enthaltend einen PLGA-Copolymer
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US7942867B2 (en) * 2005-11-09 2011-05-17 The Invention Science Fund I, Llc Remotely controlled substance delivery device
WO2007067964A2 (en) * 2005-12-08 2007-06-14 Nastech Pharmaceutical Company Inc. Mucosal delivery of stabilized formulations of exendin
EP2078197B1 (de) 2006-11-01 2016-03-23 Ventana Medical Systems, Inc. Haptene, haptenkonjugate, zusammensetzungen daraus und verfahren für ihre herstellung und verwendung
CA2671670C (en) * 2006-12-18 2015-02-10 Takeda Pharmaceutical Company Limited Sustained-release composition and method for producing the same
KR20100015520A (ko) 2007-03-13 2010-02-12 마이크로 테라퓨틱스 인코포레이티드 코일과 펴짐방지 부재를 포함하는 임플란트
EP2326304A2 (de) 2008-07-17 2011-06-01 Merial Limited Verfahren zur verbesserung der stabilität von polyorthoestern und ihren formulierungen
CA2741030A1 (en) 2008-10-20 2010-04-29 Marvin C. Gershengorn Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
EP2364082A4 (de) 2008-10-21 2012-06-06 Oregon Health And Sciences University Naphthamide als antikrebsmittel
CN101445595B (zh) * 2008-12-26 2011-01-19 上海新上化高分子材料有限公司 聚乙丙交酯及其制备方法和应用
WO2011094426A1 (en) 2010-01-29 2011-08-04 The United State Of America, As Represented By The Secretary, Department Of Health & Human Services Caspase inhibitors
AU2011237421B2 (en) 2010-04-08 2016-10-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inverse agonists and neutral antagonists for the TSH receptor
WO2012125486A1 (en) 2011-03-11 2012-09-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Combination chemotherapy for treating cancer
US9446048B2 (en) 2011-03-17 2016-09-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
CN102329269B (zh) * 2011-06-30 2013-07-17 南京大学 仿生氯化肌酐胍催化缩聚法合成高分子量聚乳酸
CN102295765B (zh) 2011-06-30 2012-11-28 南京大学 生物质肌酐催化共缩聚法合成聚乳酸-乙醇酸
WO2013039792A1 (en) 2011-09-12 2013-03-21 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Immunogens based on an hiv-1 gp120 v1v2 epitope
US20140234360A1 (en) 2011-09-30 2014-08-21 The United States of America, as represented by the Secretary, Dept.of Health and Human Services Influenza vaccine
WO2013106847A1 (en) 2012-01-13 2013-07-18 Oregon Health & Science University Compounds, compositions and associated methods comprising 3-aryl quinolines
SG11201408171SA (en) 2012-06-08 2015-01-29 Univ Pittsburgh Fbxo3 inhibitors
IN2015DN03733A (de) 2012-11-13 2015-09-18 Us Health
WO2014093702A1 (en) 2012-12-12 2014-06-19 The Usa, As Represented By The Secretary, Department Of Health And Human Services Hiv therapeutics and methods of making and using same
CN105611927A (zh) 2013-05-16 2016-05-25 美国政府(由卫生和人类服务部的部长所代表) 用于抑制耐药性hiv-1整合酶耐药株的化合物
US10882834B2 (en) 2013-09-20 2021-01-05 University of Pittsburgh—of the Commonwealth System of Higher Education Compounds for treating prostate cancer
US10398772B2 (en) 2014-01-08 2019-09-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
CA2948349C (en) 2014-05-09 2023-03-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Pyrazole derivatives and their use as cannabinoid receptor mediators
EP4070795A1 (de) 2014-08-25 2022-10-12 Salk Institute for Biological Studies Neuartige ulk1-inhibitoren und verfahren zur verwendung davon
EP3189067B1 (de) 2014-09-04 2021-05-19 The United States of America, as represented by The Secretary, Department of Health and Human Services Rekombinante hiv-1 hüllproteine und deren verwendung
WO2016064716A1 (en) 2014-10-20 2016-04-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Combination therapy of tshr antagonist and igfr inhibitor
EP3236998A1 (de) 2014-12-24 2017-11-01 The U.S.A. as represented by the Secretary, Department of Health and Human Services Rekombinante metapneumovirusproteine und deren verwendung
EP3242661B1 (de) 2015-01-05 2019-08-21 The U.S.A. as represented by the Secretary, Department of Health and Human Services Myc-g-quadruplex-stabilisierende kleine moleküle und deren verwendung
WO2016134292A1 (en) 2015-02-20 2016-08-25 Oregon Health & Science University Derivatives of sobetirome
US20180273485A1 (en) 2015-06-04 2018-09-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Cannabinoid receptor mediating compounds
EP3347047A1 (de) 2015-09-09 2018-07-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expressionsvektor-abgabesystem und dessen verwendung zur induzierung einer immunantwort
EP3423448A1 (de) 2016-03-04 2019-01-09 The U.S.A. as represented by the Secretary, Department of Health and Human Services Cannabinoid-rezeptorvermittelnde verbindungen
RS62408B1 (sr) 2016-05-18 2021-10-29 Univ Oregon Health & Science Derivati sobetiroma
EP3471828A1 (de) 2016-06-16 2019-04-24 Acies Bio d.o.o. Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch eine unzureichende pantothenatkinaseaktivität gekennzeichnet sind
CA3043790A1 (en) 2016-12-16 2018-06-21 Institute For Research In Biomedicine Novel recombinant prefusion rsv f proteins and uses thereof
EP3675921A1 (de) 2017-08-31 2020-07-08 Evonik Corporation Verbessertes reinigungsverfahren für resorbierbare polymere
WO2019118803A1 (en) 2017-12-14 2019-06-20 The United States Of America, As Represented By The Secretary,Department Of Health And Human Services Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
JP7359460B2 (ja) 2018-03-29 2023-10-11 エレックス バイオテック， インコーポレイテッド 心不整脈および心不全の処置のための化合物
AU2019349424B2 (en) 2018-09-25 2024-04-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
EP3894383A1 (de) 2018-12-12 2021-10-20 Autobahn Therapeutics, Inc. Neuartige thyromimetika
US11667606B2 (en) 2019-03-01 2023-06-06 Autobahn Therapeutics, Inc. Thyromimetics
WO2020185695A1 (en) 2019-03-11 2020-09-17 Oregon State University Analogues and derivatives of cephalotaxine and methods for making and using the compounds
WO2022261296A1 (en) 2021-06-09 2022-12-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds that bind non-canonical g-quadruplex structures and methods of making and using the same
WO2023059867A1 (en) 2021-10-08 2023-04-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds for treating or preventing alzheimer's disease
WO2023146771A1 (en) 2022-01-25 2023-08-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gingerenone a prodrugs as senotherapeutics and methods of use
WO2023177568A1 (en) 2022-03-14 2023-09-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cannabinoid receptor modulating compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1995970A (en) * 1931-04-04 1935-03-26 Du Pont Polymeric lactide resin
US2362511A (en) * 1939-11-21 1944-11-14 Du Pont Modified glycolide resins
US2438208A (en) * 1943-07-10 1948-03-23 Us Agriculture Continuous process of converting lactic acid to polylactic acid
US2683136A (en) * 1950-10-25 1954-07-06 Du Pont Copolymers of hydroxyacetic acid with other alcohol acids
US2703316A (en) * 1951-06-05 1955-03-01 Du Pont Polymers of high melting lactide
US2758987A (en) * 1952-06-05 1956-08-14 Du Pont Optically active homopolymers containing but one antipodal species of an alpha-monohydroxy monocarboxylic acid
US3531561A (en) * 1965-04-20 1970-09-29 Ethicon Inc Suture preparation
US3498957A (en) * 1965-09-14 1970-03-03 Ethicon Inc Polymerization of cyclic carboxylic esters in the presense of a nonpolymerizable ester plasticizer
US3468853A (en) * 1966-06-15 1969-09-23 American Cyanamid Co Process of polymerizing a glycolide
BE758156R (fr) * 1970-05-13 1971-04-28 Ethicon Inc Element de suture absorbable et sa
US3839297A (en) * 1971-11-22 1974-10-01 Ethicon Inc Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US4137921A (en) * 1977-06-24 1979-02-06 Ethicon, Inc. Addition copolymers of lactide and glycolide and method of preparation
US4273920A (en) * 1979-09-12 1981-06-16 Eli Lilly And Company Polymerization process and product
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions

Also Published As

Publication number Publication date
US4683288A (en) 1987-07-28
US4677191A (en) 1987-06-30
EP0172636B2 (de) 1992-11-11
EP0171907B1 (de) 1989-01-11
ATE39936T1 (de) 1989-01-15
ATE39935T1 (de) 1989-01-15
CA1256638A (en) 1989-06-27
DE3567470D1 (en) 1989-02-16
EP0171907A1 (de) 1986-02-19
SG108191G (en) 1992-06-12
EP0172636A1 (de) 1986-02-26
CA1236641A (en) 1988-05-10
BG61520B2 (bg) 1997-10-31
EP0172636B1 (de) 1989-01-11
HK19592A (en) 1992-03-20
EP0171907B2 (de) 1994-08-10

Similar Documents

Publication Publication Date Title
DE3567471D1 (en) Method for producing a polymer or copolymer of lactic acid and/or glycolic acid
ES8106542A1 (es) Un procedimiento para la preparacion de un copolimero.
US5250584A (en) Periodontium-regenerative materials
US4379138A (en) Biodegradable polymers of lactones
BE1002656A5 (fr) Matieres regeneratrices du perioste dentaire.
HUT43488A (en) Process for preparing polymers decomposing by biological process and utilizable for pharmaceutical purposes
EP0399827A3 (de) Modifizierte Polyester-Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
DE59305882D1 (de) Mitogenfreie substanz, deren herstellung sowie verwendung
EP0225163A3 (de) Kristalline Copolymere aus p-Dioxanon und Lactid und daraus geformte chirurgische Ausrüstungen
CA2001710A1 (en) Preparation process for bioabsorbable polyester
DE69006472T2 (de) Zahnärztliche Zusammensetzungen, Verfahren zur Herstellung von geformten, zahnärztlichen Artikeln via "photoiniferte Polymerisation" von zahnärztlichen Zusammensetzungen und dadurch erzeugte geformte, zahnärztliche Artikel.
ATE250663T1 (de) Kulturmedium und verfahren zur herstellung von hyaluronsäure mit hohem molekulargewicht
ATE145830T1 (de) Weicher elastischer und bioabsorbierbarer film aus milchsäurepolymer, insbesondere verwendbar zur herstellung von medizinischen verbänden
ATE106907T1 (de) Verfahren zur herstellung von polyacrylsäuren.
MXPA96003025A (es) Acido poliaspartico que tiene mas de una forma beta al 50% y menos de una forma alta al 50%.
MY102431A (en) Artificial absorbable ligament prosthesis
ATE35686T1 (de) Wasserloesliche polyester.
MY100291A (en) Dentifrice having decreased abrasivity
AU5991498A (en) Process for the polymerization of lactide
ATE29386T1 (de) Verwendung eines sulfonierten homo- oder copolymeren des styrols zur herstellung eines antikonzeptionsmittels.
DE3874440D1 (de) Zusammensetzung zur herstellung von antithrombotischen medizinischen erzeugnissen.
SG164261A1 (en) Family of xanthan-based polysaccharide polymers including non- acethylated and/or non-pyruvylated gum
EP0257567A3 (en) Resin-fortified emulsion polymers and methods of preparing the same
ES2001421A6 (es) Un metodo para producir homopolimeros y copolimeros de monomeros que contienen acido amidosulfonico o sus sales.
EP0268437A3 (de) Silizium enthaltendes Copolyester und Verfahren zur seiner Herstellung

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

Owner name: WAKO PURE CHEMICAL INDUSTRIES, LTD., OSAKA, JP